Loading
Fusobacterium Infections / Diabetes Mellitus / Cardiovascular Diseases · Journal article
Gut Microbes · June 30, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review that synthesizes existing literature on F. nucleatum's proposed role as a mediator between oral dysbiosis and systemic diseases including colorectal cancer, cardiovascular disease, adverse pregnancy outcomes, and neurodegenerative disorders. The review presents mechanistic hypotheses and proposed therapeutic strategies (adhesin blocking, outer membrane vesicle neutralization, microbiome manipulation, CRISPR) but does not report new empirical evidence or clinical trial data to support a change in practice.
Narrative review.
F. nucleatum acts as a bridging organism between early-colonizing oral commensals and late-colonizing pathogens in biofilm formation. FadA, Fap2, and RadD adhesins, along with lipopolysaccharides and outer membrane vesicles, mediate epithelial invasion and endothelial permeability. F. nucleatum is detected in atherosclerotic plaques and is associated with vascular endothelial dysfunction and cardiovascular disease risk.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review does not provide empirical evidence sufficient to guide clinical decision-making. Clinicians should view the proposed connections between F. nucleatum and systemic disease as mechanistic hypotheses warranting further investigation through rigorous clinical trials rather than as established associations ready for therapeutic intervention.
This is a narrative review synthesizing mechanistic and observational evidence about F. nucleatum's role in systemic disease, raising questions about causality and therapeutic targets rather than reporting new empirical data or clinical trials.
As stated by the source record.
This review does not provide empirical evidence sufficient to guide clinical decision-making. Clinicians should view the proposed connections between F. nucleatum and systemic disease as mechanistic hypotheses warranting further investigation through rigorous clinical trials rather than as established associations ready for therapeutic intervention.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Fusobacterium nucleatum has emerged as a pathobiont that associates oral dysbiosis with systemic diseases through coaggregation, hematogenous dissemination, and immune modulation. This review provides molecular insights through which they are involved in systemic diseases such as colorectal cancer, adverse pregnancy outcomes, cardiovascular diseases, neurodegenerative disorders, and diabetes mellitus. Key virulence factors include the adhesins of FadA, Fap2, and RadD, lipopolysaccharides, and outer membrane vesicles, which mediate epithelial invasion and endothelial permeafbility and facilitate immune suppression through TLR4-NF-κB, β-catenin/Wnt, and MAPK signaling pathways. These interactions result in impaired tissue homeostasis, propagate chronic inflammation, and promote oncogenic and metabolic modulation. Systemic pleiotropy of F. nucleatum is further substantiated by its involvement in chemoresistance, placental dysfunction, vascular inflammation, and neuronal injury, substantiating its systemic pleiotropy. Emerging therapeutic strategies, such as blocking adhesins, neutralizing outer membrane vesicles, microbiome manipulation, and using CRISPR-based clearance, provide precision techniques for mitigating diseases. Therefore, this review identifies F. nucleatum as the primary microbial mediator of oral-systemic pathology and its translational significance in the development of targeted antimicrobial and host-directed therapies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.